News
Suriname developed a high quality plasma COVID-19 treatment procedure that is more cost efficient than European methods
The Academic Medical Center (AZP) in Paramaribo, Suriname, successfully studied an efficient method to collect COVID-19 antibody-containing plasma from recovered Covid-19 patients to treat...
News
Digital transformation starts with an attitude says pharmaceutical service provider
The key to digital transformation has been indelibly linked to the latest technology. However more often, what we find is that it’s certainly not...
Clinical Trials
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
FSD Pharma Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2 study for the use of FSD201 (ultramicronized palmitoylethanolamide,...
IT & Data Management
AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
Belgium-based AARDEX Group, the world leader in medication adherence solutions, announced a strategic partnership with BIOCORP, a French company specialized in the design, development...
Clinical Trials
INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced...
News
Centus Biotherapeutics Receives European Marketing Authorization for Equidacent, Biosimilar Avastin
Centus Biotherapeutics Ltd., a joint venture between Fujifilm Kyowa Kirin Biologics Co., Ltd. and AstraZeneca, announced that the European Commission (EC) has granted the...
Press Releases
Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation
FUJIFILM Corporation announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative Executor: Wataru Akahata, hereinafter “VLP Therapeutics”)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read